PetIQ Inc (PETQ) Receives Average Recommendation of “Buy” from Analysts
PetIQ Inc (NASDAQ:PETQ) has been given a consensus rating of “Buy” by the six brokerages that are covering the firm, Marketbeat.com reports. Six investment analysts have rated the stock with a buy rating. The average 1 year price target among brokers that have issued a report on the stock in the last year is $27.20.
Separately, Jefferies Group upgraded shares of PetIQ from a “hold” rating to a “buy” rating and set a $26.00 price objective for the company in a research note on Monday, November 20th.
A number of large investors have recently modified their holdings of PETQ. American International Group Inc. acquired a new position in PetIQ during the 3rd quarter valued at about $131,000. Wells Fargo & Company MN acquired a new stake in shares of PetIQ in the 3rd quarter valued at approximately $204,000. California State Teachers Retirement System acquired a new stake in shares of PetIQ in the 3rd quarter valued at approximately $320,000. Schwab Charles Investment Management Inc. acquired a new stake in shares of PetIQ in the 3rd quarter valued at approximately $344,000. Finally, New York State Common Retirement Fund acquired a new stake in shares of PetIQ in the 3rd quarter valued at approximately $448,000. 56.49% of the stock is currently owned by hedge funds and other institutional investors.
Shares of PetIQ (NASDAQ PETQ) traded down $0.11 during trading on Monday, hitting $22.35. 223,220 shares of the stock were exchanged, compared to its average volume of 163,568. The company has a quick ratio of 4.67, a current ratio of 6.83 and a debt-to-equity ratio of 0.19. PetIQ has a twelve month low of $17.03 and a twelve month high of $28.23.
ILLEGAL ACTIVITY NOTICE: This piece of content was first reported by TheOlympiaReport and is owned by of TheOlympiaReport. If you are reading this piece of content on another publication, it was copied illegally and reposted in violation of U.S. and international trademark & copyright laws. The correct version of this piece of content can be accessed at https://theolympiareport.com/2017/12/24/petiq-inc-petq-receives-average-recommendation-of-buy-from-analysts.html.
PetIQ Company Profile
PetIQ, Inc is engaged in manufacturing and distributing pet medication and health and wellness products to the retail channel in the United States. The Company provides retail stores with third-party brands, including Frontline Plus, Heartgard Plus, PetAction Plus, Advecta II, Pet Lock Plus, Pet Lock Max, TruProfen and Heartshield.
Receive News & Ratings for PetIQ Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PetIQ and related companies with Analyst Ratings Network's FREE daily email newsletter.